2025 Annual Meeting | C31 - Adolescent/Child Neurology for the Adult Neurologist

Date Saturday 04/05/25

Time 02:30 PM - 04:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Sonika Agarwal, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
02:30 PM - 02:35 PM PDT	Introduction	Introduction: Neurology Care Across the Lifespan Sonika Agarwal, MD, FAAN
02:35 PM - 03:05 PM PDT	Introduction	Intractable Epilepsy: Transition from Pediatric to Adult Care Geetanjali S. Rathore, MD, FAAN
03:05 PM - 03:30 PM PDT	Speaker	Neurodevelopmental Disorders and Disruptive Behaviors: Diagnostic and Management Considerations Madeline A. Chadehumbe, MD, FAAN
03:30 PM - 04:00 PM PDT	Speaker	A Genetic Testing Roadmap for Neurodevelopmental Disorders in the Adult Practices Vishnu A. Cuddapah, MD
04:00 PM - 04:15 PM PDT	Closing Remarks	Growing Up with a Neurological Disorder: Creating a Community of Support Sonika Agarwal, MD, FAAN
04:15 PM - 04:30 PM PDT	Q&A	Panel for Q&A Sonika Agarwal, MD, FAAN

Faculty Disclosures
Sonika Agarwal, MD, FAAN	Dr. Agarwal has nothing to disclose.
Madeline A. Chadehumbe, MD, FAAN	Dr. Chadehumbe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Nobias.
Geetanjali S. Rathore, MD, FAAN	Dr. Rathore has nothing to disclose.
Vishnu A. Cuddapah, MD	The institution of Dr. Cuddapah has received research support from NIH. The institution of Dr. Cuddapah has received research support from CURE Epilepsy.